Newleos therapeutics Headquarters & Office Locations

Newleos therapeutics (Private) is headquartered in Boston, Massachusetts, United States. Founded in 2024, the company operates across 1 countries with approximately 20 employees worldwide.

Where is Newleos therapeutics's main office?

Newleos therapeutics's main headquarters office is located at 800 Boylston St ste. 1715, Boston, Massachusetts 02199. This serves as the company's primary corporate address and is home to its executive leadership team.

Newleos therapeutics regional offices

Beyond its headquarters in Boston, Newleos therapeutics maintains 2 offices across 1 countries. Regional offices span 1 countries.

Newleos therapeutics contact information

The main switchboard for Newleos therapeutics headquarters can be reached at 617-648-9100. For investor relations, visit newleos.com/investor-relations.

What does Newleos therapeutics do?

We are dedicated to providing a new dawn or 'eos' for patients with mental health conditions by developing next generation, first- and best-in-class therapies. Over 100 million patients in the United States are affected by neuropsychiatric disorders, with anxiety and substance use disorders among the largest areas of unmet medical need. Our clinical-stage pipeline was licensed from Roche and includes oral small molecules targeting GABAA-γ1, V1a, TAAR1 and GABAA-α5 with broad potential in general anxiety, social anxiety, substance use disorders and cognitive impairment. Newleos was co-founded by Longwood Fund, Federico Bolognani, M.D., Ph.D., and William Martin, Ph.D., seasoned experts in company creation and CNS drug development.